Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study

A. Axmon; J. Kristensson; P. Midlöv; B. Karlsson; G. Ahlström

doi:10.1111/jir.12305

Abstract

Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but without dementia, but similar levels as persons with dementia in the general population sample. They were more likely to use antipsychotics and less likely to use anticholinesterases than persons with dementia but without ID. Conclusions: Dementia in persons with ID seems to increase healthcare utilisation and drug use. However, with respect to healthcare utilisation, the levels do not exceed those found among persons with dementia in the general population.

Original language	English
Pages (from-to)	632
Number of pages	1
Journal	Journal of Intellectual Disability Research
Volume	60
Issue number	7-8
DOIs	https://doi.org/10.1111/jir.12305
Publication status	Published - 2016 Jul 1
Event	2016 IASSIDD World Congress - MELBOURNE CONVENTION AND EXHIBITION CENTRE, Melbourne, Australia Duration: 2016 Aug 14 → 2016 Aug 19

Subject classification (UKÄ)

Psychiatry
Health Care Service and Management, Health Policy and Services and Health Economy

Free keywords

acetylcholinesterase
benzodiazepine derivative
neuroleptic agent
dementia
health care utilization
hospital
human
human tissue
major clinical study
population
register

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jir.12305

Ageing persons with intellectual disability, health and mortality, healthcare utilization and social welfare: a Swedish national longitudinal population study
Ahlström, G. (PI), Kristensson, J. (Researcher), Sandberg, M. (Researcher), Axmon, A. (Researcher), Björne, P. (Researcher), Nylander, L. (CoI), Karlsson, B. (CoI), Ng, N. (Researcher), Tideman, M. (CoI) & Flygare Wallen, E. (Researcher)
Stiftelsen Ragnhild och Einar Lundströms Minne, Swedish Council for Working Life and Social Research (Forte)
2015/01/01 → 2018/10/31
Project: Research

2016 IASSIDD World Congress
Axmon, A. (Presenter), Sandberg, M. (Presenter), Kristensson, J. (Presenter) & Ahlström, G. (Presenter)
2016 Aug 14 → 2016 Aug 19
Activity: Participating in or organising an event › Participation in conference

Cite this

@article{3ee4ce66d1284718b5fcb2f14ab4ca4d,

title = "Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study",

abstract = "Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but without dementia, but similar levels as persons with dementia in the general population sample. They were more likely to use antipsychotics and less likely to use anticholinesterases than persons with dementia but without ID. Conclusions: Dementia in persons with ID seems to increase healthcare utilisation and drug use. However, with respect to healthcare utilisation, the levels do not exceed those found among persons with dementia in the general population.",

keywords = "acetylcholinesterase, benzodiazepine derivative, neuroleptic agent, dementia, health care utilization, hospital, human, human tissue, major clinical study, population, register",

author = "A. Axmon and J. Kristensson and P. Midl{\"o}v and B. Karlsson and G. Ahlstr{\"o}m",

year = "2016",

month = jul,

day = "1",

doi = "10.1111/jir.12305",

language = "English",

volume = "60",

pages = "632",

journal = "Journal of Intellectual Disability Research",

issn = "0964-2633",

publisher = "Wiley-Blackwell",

number = "7-8",

note = "2016 IASSIDD World Congress ; Conference date: 14-08-2016 Through 19-08-2016",

}

TY - JOUR

T1 - Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study

AU - Axmon, A.

AU - Kristensson, J.

AU - Midlöv, P.

AU - Karlsson, B.

AU - Ahlström, G.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but without dementia, but similar levels as persons with dementia in the general population sample. They were more likely to use antipsychotics and less likely to use anticholinesterases than persons with dementia but without ID. Conclusions: Dementia in persons with ID seems to increase healthcare utilisation and drug use. However, with respect to healthcare utilisation, the levels do not exceed those found among persons with dementia in the general population.

AB - Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but without dementia, but similar levels as persons with dementia in the general population sample. They were more likely to use antipsychotics and less likely to use anticholinesterases than persons with dementia but without ID. Conclusions: Dementia in persons with ID seems to increase healthcare utilisation and drug use. However, with respect to healthcare utilisation, the levels do not exceed those found among persons with dementia in the general population.

KW - acetylcholinesterase

KW - benzodiazepine derivative

KW - neuroleptic agent

KW - dementia

KW - health care utilization

KW - hospital

KW - human

KW - human tissue

KW - major clinical study

KW - population

KW - register

U2 - 10.1111/jir.12305

DO - 10.1111/jir.12305

M3 - Published meeting abstract

SN - 0964-2633

VL - 60

SP - 632

JO - Journal of Intellectual Disability Research

JF - Journal of Intellectual Disability Research

IS - 7-8

T2 - 2016 IASSIDD World Congress

Y2 - 14 August 2016 through 19 August 2016

ER -

Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study

Abstract

Subject classification (UKÄ)

Free keywords

UN SDGs

Access to Document

Fingerprint

Projects

Ageing persons with intellectual disability, health and mortality, healthcare utilization and social welfare: a Swedish national longitudinal population study

Activities

2016 IASSIDD World Congress

Cite this